LEENO Industrial (A058470) Q4 2024 earnings summary

Executive summary

• Revenue for FY2024 was KRW 278.2 billion, up 9% year-over-year, driven by growth in both semiconductor test equipment and medical device components.

• Operating income rose 9% to KRW 124.2 billion, with net income up 2% to KRW 113.3 billion, reflecting strong cost control and product demand.

• The company maintained a high operating margin of 44.6% and continued its debt-free management.

• Major investments included a new factory project to expand production and R&D capabilities, funded entirely with internal cash.

Financial highlights

• Total assets increased 13% to KRW 657.4 billion, with equity up 12% to KRW 622.6 billion.

• Cash and cash equivalents at year-end were KRW 54.8 billion.

• Dividend payout was KRW 45.5 billion, with a payout ratio of 40.2% and dividend yield of 1.57%.

• No new shares or debt securities were issued during the year.

Outlook and guidance

• The company plans to maintain a dividend payout ratio around 30% of net income, subject to business performance.

• Ongoing investments in new production facilities are expected to enhance capacity and support future growth.

• Management highlights continued focus on operational efficiency, quality, and strategic business expansion.